L01F — Monoklonālās antivielas un antivielas-zāļu konjugāti
Monoklonālās antivielas un antivielas-zāļu konjugāti (MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES)
| Aktīvā viela | Zāļu nosaukumi |
|---|---|
| Amivantamabum | Rybrevant |
| Atezolizumabum | Tecentriq |
| Avelumabum | Bavencio |
| Belantamabum mafodotinum | Blenrep |
| Bevacizumabum | Abevmy, Alymsys, Avastin, Avzivi, Aybintio, MVASI |
| Blinatumomabum | Blincyto |
| Brentuximab vedotin | Adcetris |
| Catumaxomabum | Korjuny |
| Cemiplimabum | LIBTAYO |
| Cetuximabum | Erbitux |
| Daratumumabum | Darzalex |
| Datopotamabum deruxtecanum | Datroway |
| Dinutuximabum beta | Qarziba |
| Dostarlimabum | Jemperli |
| Durvalumabum | Imfinzi |
| Elotuzumabum | Empliciti |
| Elranatamabum | Elrexfio |
| Enfortumabum vedotinum | Padcev |
| Epcoritamabum | Tepkinly |
| Gemtuzumabum ozogamicinum | Mylotarg |
| Glofitamabum | Columvi |
| Inotuzumabum ozogamicinum | Besponsa |
| Ipilimumabum | Yervoy |
| Isatuximabum | SARCLISA |
| Linvoseltamabum | Lynozyfic |
| Loncastuximabum tesirinum | Zynlonta |
| Mirvetuximabum soravtansinum | Elahere |
| Mogamulizumabum | Poteligeo |
| Mosunetuzumabum | Lunsumio |
| Nivolumabum | Opdivo |
| Nivolumabum, Relatlimabum | Opdualag |
| Obinutuzumabum | Gazyvaro |
| Odronextamabum | Ordspono |
| Panitumumabum | Vectibix |
| Pembrolizumabum | Keytruda |
| Pertuzumabum | Perjeta, Poherdy |
| Pertuzumabum, Trastuzumabum | Phesgo |
| Polatuzumabum vedotinum | Polivy |
| Ramucirumabum | Cyramza |
| Retifanlimabum | Zynyz |
| Rituximabum | Blitzima, Ituxredi, MabThera, Rixathon, Riximyo, Ruxience |
| Sacituzumabum govitecanum | Trodelvy |
| Serplulimabum | Hetronifly |
| Sugemalimabum | Cejemly |
| Tafasitamabum | Minjuvi |
| Talquetamabum | Talvey |
| Tarlatamabum | Imdylltra |
| Teclistamabum | Tecvayli |
| Tislelizumabum | Tevimbra |
| Tisotumabum vedotinum | Tivdak |
| Toripalimabum | Loqtorzi |
| Trastuzumabum | Dazublys, Herceptin, Herwenda, Herzuma, Kanjinti, Ogivri |
| Trastuzumabum deruxtecanum | Enhertu |
| Trastuzumabum emtansinum | Kadcyla |
| Tremelimumabum | IMJUDO |
| Zanidatamabum | Ziihera |
| Zolbetuximabum | Vyloy |
Kompensējamās zāles
Šajā grupā 20 ATĶ kodi ir NVD kompensējamo zāļu sarakstā. Saraksts spēkā no 01.07.2026.
NVD20izraksta speciālists
| ATĶ | Aktīvā viela | Kompensācija | Izrakstīšana |
|---|---|---|---|
| L01FA01 | Rituximabum | 100%, 75% | NVD |
| L01FA03 | Obinutuzumabum | 100% | NVD |
| L01FC01 | Daratumumabum | 100% | NVD |
| L01FD01 | Trastuzumabum | 100% | NVD |
| L01FD02 | Pertuzumabum + Trastuzumabum | 100% | NVD |
| L01FD03 | Trastuzumabum emtansinum | 100% | NVD |
| L01FD04 | Trastuzumabum deruxtecanum | 100% | NVD |
| L01FE01 | Cetuximabum | 100% | NVD |
| L01FE02 | Panitumumabum | 100% | NVD |
| L01FF01 | Nivolumabum (240mg vai 600mg deva), Nivolumabum | 100% | NVD |
| L01FF02 | Pembrolizumabum | 100% | NVD |
| L01FF03 | Durvalumabum | 100% | NVD |
| L01FF05 | Atezolizumabum | 100% | NVD |
| L01FF06 | Cemiplimabum | 100% | NVD |
| L01FX04 | Ipilimumabum | 100% | NVD |
| L01FX05 | Brentuximabum vedotin | 100% | NVD |
| L01FX06 | Dinutuximabum beta | 100% | NVD |
| L01FX07 | Blinatumomabum | 100% | NVD |
| L01FX14 | Polatuzumabum vedotinum | 100% | NVD |
| L01FY01 | Pertuzumabum/Trastuzumabum | 100% | NVD |
Apakšgrupas
L01FA - CD20 (diferenciācijas klasteris 20) inhibitori
L01FB - CD22 (diferenciācijas klasteris 22) inhibitori
L01FC - CD38 (diferenciācijas klasteris 38) inhibitori
L01FD - HER2 (cilvēka epidermālā augšanas faktora receptors 2) inhibitori
L01FE - EGFR (epidermālā augšanas faktora receptors) inhibitori
L01FF - PD-1/PDL-1 (programmētās šūnu nāves proteīns 1/nāves ligands 1) inhibitori
L01FG - VEGF/VEGFR (vaskulārā endotēlija augšanas faktors) inhibitori
L01FX - Citas monoklonālās antivielas un antivielas-zāļu konjugāti
L01FY - Monoklonālo antivielu un antivielu-zāļu konjugātu kombinācijas
Avots: Zāļu valsts aģentūras Zāļu reģistrs · ATĶ klasifikators: data.gov.lv · kompensācija: NVD kompensējamo zāļu saraksts